How do the restricted share units granted to William D. Young at Autolus (AUTL) vest?

The 31,667 restricted share units vest in one installment on June 29, 2027. Once vested, each unit entitles him to receive one American Depositary Share, providing a time-based incentive to remain with the company until that date.

Do William D. Young’s restricted share units at Autolus (AUTL) convert into ordinary shares?

Each restricted share unit represents a right to receive one American Depositary Share. Each American Depositary Share is, in turn, convertible at any time at his option into one ordinary share, linking the RSUs directly to the company’s ordinary equity.

Autolus director awarded options and RSUs

Autolus Therapeutics plc director William D. Young received equity-based compensation awards.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Autolus Therapeutics plc director William D. Young received equity-based compensation awards. On June 29, 2026, he was granted options to purchase 47,500 American Depositary Shares at an exercise price of $1.61 per share, vesting in twelve equal monthly installments starting on July 29, 2026.

He was also granted 31,667 restricted share units, each representing one American Depositary Share, vesting in a single installment on June 29, 2027. Following these awards, his reported holdings in these instruments match the granted amounts.

Insider Trade Summary

Grant/Award: 79,167 shares

Grant/Award 2 txns

Insider YOUNG WILLIAM D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	31,667	$0.00	$0.00
Grant/Award	Share Option (Right to Buy)	47,500	$0.00	$0.00

Holdings After Transaction: Restricted Share Units — 31,667 contracts (Direct); Share Option (Right to Buy) — 47,500 contracts (Direct)

Footnotes (3)

F1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
F2. The RSUs vest in one installment on June 29, 2027.
F3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

Key Figures

Options granted: 47,500 options Option exercise price: $1.61 per share Option expiration: June 29, 2036 +3 more

6 metrics

Options granted 47,500 options Grant on June 29, 2026 over American Depositary Shares

Option exercise price $1.61 per share Exercise price for granted options

Option expiration June 29, 2036 Expiration date of granted options

RSUs granted 31,667 RSUs Grant on June 29, 2026 tied to ADSs

RSU vesting date June 29, 2027 Single-installment vesting for RSUs

Option vesting schedule 12 monthly installments Vesting begins July 29, 2026

Key Terms

Restricted Share Units, American Depositary Shares, Share Option (Right to Buy), vest

4 terms

American Depositary Shares financial

"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

vest financial

"Share options vest in twelve equal monthly installments commencing on July 29, 2026."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Autolus Therapeutics (AUTL) director William D. Young receive?

William D. Young received two equity awards: options over 47,500 American Depositary Shares at $1.61 per share and 31,667 restricted share units. These awards represent stock-based compensation rather than open-market share purchases or sales.

When do William D. Young’s new stock options in Autolus Therapeutics (AUTL) vest?

The 47,500 stock options vest in twelve equal monthly installments starting on July 29, 2026. This means a fraction of the options becomes exercisable each month over one year, aligning incentives with ongoing service to the company.

What is the exercise price of William D. Young’s Autolus (AUTL) stock options?

The granted options have an exercise price of $1.61 per American Depositary Share. This is the price at which he can buy shares once the options vest, regardless of the market price at that time, until the options expire on June 29, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/01/2026 - 04:21 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

YOUNG WILLIAM D

(Last)

(First)

(Middle)

THE MEDIAWORKS, WHITE CITY

C/O AUTOLUS THERAPEUTICS PLC

(Street)

LONDON

W12 7FP

(City)

(State)

(Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Autolus Therapeutics plc [ AUTL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Share Units	⁽¹⁾	06/29/2026		A		31,667		⁽²⁾	⁽²⁾	American Depositary Shares	31,667	$0	31,667	D
Share Option (Right to Buy)	$1.61	06/29/2026		A		47,500		⁽³⁾	06/29/2036	American Depositary Shares	47,500	$0	47,500	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.

2. The RSUs vest in one installment on June 29, 2027.

3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

	/s/ William Young	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR